FindTrial
Sign In

COMPARISON OF TWO DIFFERNT TYPE OF FLUID THERAPIES FOR INTRAOPERATIVE BRAIN CONDITION, IN PATIENTS UNDERGOING BRAIN TUMORS SURGERY

COMPARISON OF 0.9% SALINE VERSUS PLASMA-LYTE A FOR BRAIN RELAXATION IN PATIENTS UNDERGOING SUPRATENTORIAL TUMORS RESECTION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/09/007274
Enrollment
110
Registered
2016-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I AND II PATIENTS UNDERGOING SURGERY FOR SUPRATENTORIAL BRAIN TUMORS Health Condition 2: C712- Malignant neoplasm of temporal lobe

Interventions

Intervention1: Jugluar venous oxymetry: â?¢ Juglar bulb catheter: The patients were placed flat in supine position with head in neutral position or slightly tilted away from the side of insertion. Ant

Sponsors

PGIMER CHANDIGARH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Patients scheduled to undergo craniotomy for supratentorial tumors (2) ASA-I and II patients. (3) 18 â?? 65 yrs of age

Exclusion criteria

Exclusion criteria: (1) Pre-operative hypernatremia or hyponatremia (serum Na 150mEq/L). (2) History of congestive heart failure, kidney disease, chronic obstructive airway disease. (3) History of ventriculoperitoneal (VP) shunt. (4) Initial serum osmolarity >320mosm/kg.

Design outcomes

Primary

MeasureTime frame
Effect of 0.9% saline versus Plasma-Lyte A on intraoperative degree of brain relaxation in patients undergoing surgery for supratentorial tumors.Timepoint: AT THE TIME OF BONE FLAP ELAVATION , DURING CRANIOTOMY FOR TUMOR RESECTION—

Secondary

MeasureTime frame
Effect of 0.9% saline versus Plasma-Lyte A on Hemodynamics variable, Electrolyte changes, Serum osmolarity, Jugular venous oximetry and metabolism variabl,Post op complication, Duration of Hospital stay, MRSA at discharge Timepoint: till patient discharge or death—

Countries

India

Contacts

Public ContactDR SHIV LAL SONI

PGIMER,CHANDIGARH

hembhagat@rediffmail.com01722756500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026